Lincoln National Corp’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,400
Closed -$732K 202
2024
Q1
$732K Sell
3,400
-421
-11% -$88.4K 0.01% 612
2023
Q4
$805K Buy
3,821
+41
+1% +$8.75K 0.01% 512
2023
Q3
$757K Buy
3,780
+378
+11% +$75.1K 0.02% 482
2023
Q2
$630K Buy
3,402
+217
+7% +$40.1K 0.01% 521
2023
Q1
$610K Buy
3,185
+1,047
+49% +$189K 0.01% 521
2022
Q4
$360K Buy
2,138
+676
+46% +$117K 0.01% 634
2022
Q3
$259K Buy
1,462
+251
+21% +$49.6K 0.01% 706
2022
Q2
$247K Buy
1,211
+58
+5% +$12.3K 0.01% 729
2022
Q1
$275K Buy
+1,153
New +$271K 0.01% 739

Other funds holding CME

Lincoln National Corp's CME Position: Q2 2024 in Review

Lincoln National Corp sold out of CME Group (CME) in Q2 2024, closing a stake of 3,400 shares — an estimated $732K sold.

Lincoln National Corp first reported a position in CME in Q1 2022 and held it in 9 quarters. The position peaked at $805K in Q4 2023. 1,377 funds tracked by Wall St. Rank hold CME as of Q2 2024.

  • Lincoln National Corp reported no remaining CME Group position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 3,400 CME Group shares in Q2 2024, an estimated $732K.
  • Lincoln National Corp first reported a position in CME Group in Q1 2022 and held it in 9 quarters.
  • Lincoln National Corp's CME Group position peaked at $805K in Q4 2023.
  • 1,377 funds tracked by Wall St. Rank held CME Group as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.